{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:15:36Z","timestamp":1793330136834,"version":"4.5.0"},"reference-count":166,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is an increasingly prevalent condition characterized by abnormal fat accumulation in the liver, often associated with metabolic disorders. Emerging evidence suggests a potential link between vitamin D deficiency and the development and progression of MASLD. The current review provides a concise overview of recent studies uncovering novel mechanistic insights into the interplay between vitamin D and MASLD. Several epidemiological studies have highlighted a significant association between low vitamin D levels and an increased risk of MASLD. Vitamin D, traditionally known for its role in bone health, has now been recognized as a key player in various physiological processes, including immune regulation and inflammation. Experimental studies using animal models have demonstrated that vitamin D deficiency exacerbates liver steatosis and inflammation, suggesting a potential protective role against MASLD. Mechanistically, vitamin D appears to modulate MASLD through multiple pathways. Firstly, the vitamin D receptor (VDR) is abundantly expressed in liver cells, indicating a direct regulatory role in hepatic function. Activation of the VDR has been shown to suppress hepatic lipid accumulation and inflammation, providing a mechanistic basis for the observed protective effects. Additionally, vitamin D influences insulin sensitivity, a critical factor in MASLD pathogenesis. Improved insulin sensitivity may mitigate the excessive accumulation of fat in the liver, thus attenuating MASLD progression. In parallel, vitamin D exhibits anti-inflammatory properties by inhibiting pro-inflammatory cytokines implicated in MASLD pathophysiology. Experimental evidence suggests that the immunomodulatory effects of vitamin D extend to the liver, reducing inflammation and oxidative stress, key drivers of MASLD, and the likelihood of hepatocyte injury and fibrosis. Understanding the complex interplay between vitamin D and MASLD provides a basis for exploring targeted therapeutic strategies and preventive interventions. As vitamin D deficiency is a modifiable risk factor, addressing this nutritional concern may prove beneficial in mitigating the burden of MASLD and associated metabolic disorders.<\/jats:p>","DOI":"10.3390\/ijms25094901","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T03:30:49Z","timestamp":1714534249000},"page":"4901","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4489-1485","authenticated-orcid":false,"given":"Ioanna","family":"Aggeletopoulou","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2797-5070","authenticated-orcid":false,"given":"Efthymios P.","family":"Tsounis","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3094-8209","authenticated-orcid":false,"given":"Christos","family":"Triantos","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"ref_1","first-page":"e50159","article-title":"A Comprehensive Review on Non-Alcoholic Fatty Liver Disease","volume":"15","author":"Sahu","year":"2023","journal-title":"Cureus"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2023.11.004","article-title":"Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Phoolchund, A.G.S., and Khakoo, S.I. (2024). MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges. Cancers, 16.","DOI":"10.3390\/cancers16020259"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7570\/jomes22021","article-title":"Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease","volume":"31","author":"Huh","year":"2022","journal-title":"J. Obes. Metab. Syndr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: A systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of Nonalcoholic Steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep4.1134","article-title":"Natural history of nonalcoholic fatty liver disease: A prospective follow-up study with serial biopsies","volume":"2","author":"Nasr","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s12072-023-10550-9","article-title":"Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: A single-centre prospective cohort study with baseline liver biopsy","volume":"17","author":"Chan","year":"2023","journal-title":"Hepatol. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/1389557518666181025153712","article-title":"Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables","volume":"19","author":"Pacifico","year":"2019","journal-title":"Mini. Rev. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Barchetta, I., Cimini, F.A., and Cavallo, M.G. (2020). Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update. Nutrients, 12.","DOI":"10.3390\/nu12113302"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"122124","DOI":"10.1016\/j.lfs.2023.122124","article-title":"Insights into the role of vitamin D in targeting the culprits of non-alcoholic fatty liver disease","volume":"332","author":"Abdelrahman","year":"2023","journal-title":"Life Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14728222.2023.2274099","article-title":"Vitamin D\/vitamin D receptor pathway in non-alcoholic fatty liver disease","volume":"27","author":"Liu","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_17","unstructured":"World Health Organization (2024, April 11). Obesity and Overweight. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study","volume":"71","author":"Haldar","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wainwright, P., and Byrne, C.D. (2016). Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030367"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mantovani, A., Taverna, A., Cappelli, D., Beatrice, G., Csermely, A., Sani, E., Byrne, C.D., and Targher, G. (2022). Long-term adverse effect of liver stiffness on glycaemic control in type 2 diabetic patients with nonalcoholic fatty liver disease: A pilot study. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012481"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: Clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"20704","DOI":"10.3390\/ijms141020704","article-title":"Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)","volume":"14","author":"Takaki","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"Ding","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0036-1593880","article-title":"The Metabolic Role of the Microbiome: Implications for NAFLD and the Metabolic Syndrome","volume":"36","author":"Quigley","year":"2016","journal-title":"Semin. Liver Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/10715762.2013.837577","article-title":"Involvement of free radicals and oxidative stress in NAFLD\/NASH","volume":"47","author":"Sumida","year":"2013","journal-title":"Free. Radic. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13930","DOI":"10.1038\/ncomms13930","article-title":"The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma","volume":"8","author":"Sheppard","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/nu5010111","article-title":"Vitamin D\u2014Effects on skeletal and extraskeletal health and the need for supplementation","volume":"5","author":"Wacker","year":"2013","journal-title":"Nutrients"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.mayocp.2013.05.011","article-title":"Vitamin D for health: A global perspective","volume":"88","author":"Holick","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00394-012-0430-5","article-title":"Vitamin D metabolism, functions and needs: From science to health claims","volume":"52","author":"Battault","year":"2013","journal-title":"Eur. J. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/apt.12553","article-title":"Review article: Vitamin D and inflammatory bowel diseases","volume":"39","author":"Mouli","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/hep.31699","article-title":"Vitamin D\u2014Liver disease association: Biological basis and mechanisms of action","volume":"74","author":"Triantos","year":"2021","journal-title":"Hepatology"},{"key":"ref_35","first-page":"e10558","article-title":"FGF23 and Vitamin D Metabolism","volume":"5","author":"Latic","year":"2021","journal-title":"J. Bone Miner. Res. Plus"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jsbmb.2006.12.078","article-title":"Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease","volume":"103","author":"Hewison","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/gut.2010.234666","article-title":"Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats","volume":"60","author":"Abramovitch","year":"2011","journal-title":"Gut"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.23489","article-title":"Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C","volume":"51","author":"Petta","year":"2010","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1478-3231.2011.02735.x","article-title":"Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease","volume":"32","author":"Pilz","year":"2012","journal-title":"Liver Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/eci.12205","article-title":"Vitamin D deficiency is associated with mortality in patients with advanced liver cirrhosis","volume":"44","author":"Stokes","year":"2014","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1631\/jzus.B1400073","article-title":"Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: A systematic meta-analysis","volume":"15","author":"Luo","year":"2014","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jhep.2013.03.024","article-title":"Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease","volume":"59","author":"Trepo","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/apt.13244","article-title":"Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis","volume":"42","author":"Guo","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cgh.2006.10.015","article-title":"Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease","volume":"5","author":"Fisher","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3748\/wjg.v17.i7.922","article-title":"Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology","volume":"17","author":"Malham","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/MEG.0000000000001597","article-title":"Vitamin D-related immunomodulation in patients with liver cirrhosis","volume":"32","author":"Triantos","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/hep.27281","article-title":"Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: A meta-analysis","volume":"60","author":"Resino","year":"2014","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jhep.2011.01.041","article-title":"Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis","volume":"55","author":"Terrier","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/j.1753-4887.2008.00093.x","article-title":"Vitamin D receptor: Molecular signaling and actions of nutritional ligands in disease prevention","volume":"66","author":"Haussler","year":"2008","journal-title":"Nutr. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"86812","DOI":"10.3389\/fphys.2014.00167","article-title":"Genome-wide (over)view on the actions of vitamin D","volume":"5","author":"Carlberg","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fendo.2018.00250","article-title":"Vitamin D genomics: From in vitro to in vivo","volume":"9","author":"Carlberg","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_52","first-page":"26","article-title":"Nonclassic actions of vitamin D","volume":"94","author":"Bikle","year":"2009","journal-title":"Front. Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.biopha.2018.10.140","article-title":"Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies","volume":"109","author":"Udomsinprasert","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1210\/en.2006-0946","article-title":"Minireview: Vitamin D receptor: New assignments for an already busy receptor","volume":"147","author":"Norman","year":"2006","journal-title":"Endocrinology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/jhep.2003.50176","article-title":"The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells","volume":"37","author":"Demers","year":"2003","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/abbi.1999.1605","article-title":"Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system","volume":"374","author":"Veldman","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00109-010-0590-9","article-title":"Vitamin D and molecular actions on the immune system: Modulation of innate and autoimmunity","volume":"88","author":"Kamen","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e2097","DOI":"10.31661\/gmj.v10i.2097","article-title":"Molecular Mechanisms of Vitamin D-Mediated Immunomodulation","volume":"10","author":"Shah","year":"2021","journal-title":"Galen. Med. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1073\/pnas.121172198","article-title":"Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo","volume":"98","author":"Griffin","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ni.1851","article-title":"Vitamin D controls T cell antigen receptor signaling and activation of human T cells","volume":"11","author":"Kongsbak","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/er.2004-0002","article-title":"Noncalcemic actions of vitamin D receptor ligands","volume":"26","author":"Nagpal","year":"2005","journal-title":"Endocr. Rev."},{"key":"ref_62","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","author":"Itagaki","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.3748\/wjg.v26.i38.5812","article-title":"Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis?","volume":"26","author":"Cao","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_64","first-page":"297","article-title":"Vitamin D deficiency in patients with liver cirrhosis","volume":"29","author":"Konstantakis","year":"2016","journal-title":"Ann. Gastroenterol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbadis.2017.01.001","article-title":"Vitamin D in liver disease: Current evidence and potential directions","volume":"4","author":"Elangovan","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/hep.24737","article-title":"Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation","volume":"55","author":"Roth","year":"2012","journal-title":"Hepatology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jhep.2016.05.031","article-title":"Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis","volume":"65","author":"Bozic","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fphys.2016.00498","article-title":"Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models","volume":"7","author":"Su","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"G542","DOI":"10.1152\/ajpgi.00286.2019","article-title":"Vitamin D signaling maintains intestinal innate immunity and gut microbiota: Potential intervention for metabolic syndrome and NAFLD","volume":"318","author":"Zeng","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"42324","DOI":"10.1074\/jbc.M112.407833","article-title":"Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-\u03b3-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes","volume":"287","author":"Manna","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jnutbio.2017.08.007","article-title":"Circulating levels of miR-7, miR-152 and miR-192 respond to vitamin D supplementation in adults with prediabetes and correlate with improvements in glycemic control","volume":"49","author":"Pittas","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.clinre.2019.10.007","article-title":"Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model","volume":"44","author":"Ma","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1507\/endocrj.EJ16-0542","article-title":"Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model","volume":"64","author":"Zhu","year":"2017","journal-title":"Endocr. J."},{"key":"ref_74","first-page":"410","article-title":"Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients","volume":"44","author":"Wu","year":"2014","journal-title":"Ann. Clin. Lab Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40618-015-0287-6","article-title":"1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats","volume":"38","author":"Wang","year":"2015","journal-title":"J. Endocrinol. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/gutjnl-2014-307024","article-title":"Vitamin D counteracts fibrogenic TGF-\u03b2 signalling in human hepatic stellate cells both receptor-dependently and independently","volume":"64","author":"Beilfuss","year":"2015","journal-title":"Gut"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Barchetta, I., Cimini, F.A., and Cavallo, M.G. (2017). Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future. Nutrients, 9.","DOI":"10.3390\/nu9091015"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1074\/jbc.RA119.011487","article-title":"Vitamin D receptor targets hepatocyte nuclear factor 4\u03b1 and mediates protective effects of vitamin D in nonalcoholic fatty liver disease","volume":"295","author":"Zhang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"172761","DOI":"10.1016\/j.ejphar.2019.172761","article-title":"VDR regulates energy metabolism by modulating remodeling in adipose tissue","volume":"865","author":"Xu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Jonas, M.I., and Kury\u0142owicz, A. (2019). Vitamin D Receptor Gene Expression in Adipose Tissue of Obese Individuals is Regulated by miRNA and Correlates with the Pro-Inflammatory Cytokine Level. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215272"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.bbadis.2019.03.007","article-title":"Intestinal vitamin D receptor modulates lipid metabolism, adipose tissue inflammation and liver steatosis in obese mice","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.ajpath.2018.07.028","article-title":"Angiopoietin-Like Protein 8 Is a Novel Vitamin D Receptor Target Gene Involved in Nonalcoholic Fatty Liver Pathogenesis","volume":"188","author":"Petrov","year":"2018","journal-title":"Am. J. Pathol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","article-title":"Regulation mechanisms and signaling pathways of autophagy","volume":"43","author":"He","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e108863","DOI":"10.15252\/embj.2021108863","article-title":"Autophagy in major human diseases","volume":"40","author":"Klionsky","year":"2021","journal-title":"EMBO J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jhep.2019.01.026","article-title":"Autophagy in liver diseases: Time for translation?","volume":"70","author":"Allaire","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI73938","article-title":"Development of autophagy inducers in clinical medicine","volume":"125","author":"Levine","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-981-10-8684-7_10","article-title":"Autophagy, NAFLD and NAFLD-Related HCC","volume":"1061","author":"Wu","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.livres.2018.09.004","article-title":"Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease","volume":"2","author":"Khambu","year":"2018","journal-title":"Liver Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.3748\/wjg.v20.i23.7325","article-title":"Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: A controversial issue","volume":"20","author":"Kwanten","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e1179","DOI":"10.1038\/cddis.2014.162","article-title":"Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD","volume":"5","author":"Mayoral","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/hep.28820","article-title":"Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice","volume":"64","author":"Tanaka","year":"2016","journal-title":"Hepatology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jsbmb.2017.02.007","article-title":"1,25-Dihydroxyvitamin-D3 prevents the development of diabetic cardiomyopathy in type 1 diabetic rats by enhancing autophagy via inhibiting the \u03b2-catenin\/TCF4\/GSK-3\u03b2\/mTOR pathway","volume":"168","author":"Wei","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1080\/15548627.2020.1822088","article-title":"Vitamin D3-VDR-PTPN6 axis mediated autophagy contributes to the inhibition of macrophage foam cell formation","volume":"17","author":"Kumar","year":"2021","journal-title":"Autophagy"},{"key":"ref_95","first-page":"2630","article-title":"The role of 1,25-dyhydroxyvitamin D3 in mouse liver ischemia reperfusion injury: Regulation of autophagy through activation of MEK\/ERK signaling and PTEN\/PI3K\/Akt\/mTORC1 signaling","volume":"7","author":"Yang","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Bhutia, S.K. (2022). Vitamin D in autophagy signaling for health and diseases: Insights on potential mechanisms and future perspectives. J. Nutr. Biochem., 99.","DOI":"10.1016\/j.jnutbio.2021.108841"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/oby.21757","article-title":"1,25(OH)(2) D(3) attenuates hepatic steatosis by inducing autophagy in mice","volume":"25","author":"Li","year":"2017","journal-title":"Obesity"},{"key":"ref_98","first-page":"190","article-title":"Vitamin D-induced autophagy prevents steatosis","volume":"13","author":"Holmes","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/1535370220987524","article-title":"Effect of vitamin D(3) supplementation on hepatic lipid dysregulation associated with autophagy regulatory AMPK\/Akt-mTOR signaling in type 2 diabetic mice","volume":"246","author":"Lim","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Abdelrahman, B.A., Hammam, O.A., El-Khatib, A.S., and Attia, Y.M. (2023). The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH. Biochem. Biophys. Res. Commun., 688.","DOI":"10.1016\/j.bbrc.2023.149122"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Wei, J., and Fang, D. (2021). Endoplasmic Reticulum Stress Signaling and the Pathogenesis of Hepatocarcinoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041799"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13679-021-00431-3","article-title":"Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives","volume":"10","author":"Flessa","year":"2021","journal-title":"Curr. Obes. Rep."},{"key":"ref_103","first-page":"119","article-title":"Endoplasmic reticulum stress response and pathogenesis of non-alcoholic steatohepatitis","volume":"36","author":"Blanc","year":"2020","journal-title":"Med. Sci."},{"key":"ref_104","first-page":"2036","article-title":"The mechanisms and strategies to protect from hepatic ischemia-reperfusion injury","volume":"19","author":"Li","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.30887","article-title":"Vitamin D Receptor Activation in Liver Macrophages Protects Against Hepatic Endoplasmic Reticulum Stress in Mice","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fimmu.2017.01299","article-title":"Hyperglycemia Aggravates Hepatic Ischemia and Reperfusion Injury by Inhibiting Liver-Resident Macrophage M2 Polarization via C\/EBP Homologous Protein-Mediated Endoplasmic Reticulum Stress","volume":"8","author":"Rao","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.freeradbiomed.2018.06.043","article-title":"IRE1\u03b1 aggravates ischemia reperfusion injury of fatty liver by regulating phenotypic transformation of kupffer cells","volume":"124","author":"Yang","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_108","first-page":"777","article-title":"Vitamin D receptor alleviates hepatic ischemia and reperfucion injury by mediating endoplasmic reticulum stress through autophagy","volume":"72","author":"Fang","year":"2021","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3389\/fimmu.2017.01882","article-title":"Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases","volume":"8","author":"Li","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Teunis, C., Nieuwdorp, M., and Hanssen, N. (2022). Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases. Metabolites, 12.","DOI":"10.3390\/metabo12060514"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/apt.15314","article-title":"Review article: Emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications","volume":"50","author":"Jayakumar","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ajpath.2023.02.004","article-title":"Vitamin D and Microbiome: Molecular Interaction in Inflammatory Bowel Disease Pathogenesis","volume":"193","author":"Aggeletopoulou","year":"2023","journal-title":"Am. J. Pathol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"551","DOI":"10.21873\/anticanres.13984","article-title":"The Effect of Various Doses of Oral Vitamin D(3) Supplementation on Gut Microbiota in Healthy Adults: A Randomized, Double-blinded, Dose-response Study","volume":"40","author":"Charoenngam","year":"2020","journal-title":"Anticancer. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.clinthera.2015.04.004","article-title":"Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome","volume":"37","author":"Jin","year":"2015","journal-title":"Clin. Ther."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Fakhoury, H.M.A., Kvietys, P.R., AlKattan, W., Anouti, F.A., Elahi, M.A., Karras, S.N., and Grant, W.B. (2020). Vitamin D and intestinal homeostasis: Barrier, microbiota, and immune modulation. J. Steroid Biochem. Mol. Biol., 200.","DOI":"10.1016\/j.jsbmb.2020.105663"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3389\/fphys.2018.01813","article-title":"Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease","volume":"9","author":"Porras","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s10620-015-3710-0","article-title":"Does Vitamin D Protect the Gut Mucosal Barrier? Mechanistic Insights from Experimental Colitis","volume":"60","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mce.2017.04.010","article-title":"Vitamin D signaling in intestinal innate immunity and homeostasis","volume":"453","author":"Dimitrov","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"106112","DOI":"10.1016\/j.intimp.2019.106112","article-title":"Vitamin D and microbiota: Two sides of the same coin in the immunomodulatory aspects","volume":"79","author":"Malaguarnera","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neo.2016.10.007","article-title":"H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells","volume":"19","author":"Chen","year":"2017","journal-title":"Neoplasia"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"G208","DOI":"10.1152\/ajpgi.00398.2007","article-title":"Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier","volume":"294","author":"Kong","year":"2008","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1248\/bpb.b20-00432","article-title":"A Lipid-Based Nanocarrier Containing Active Vitamin D(3) Ameliorates NASH in Mice via Direct and Intestine-Mediated Effects on Liver Inflammation","volume":"43","author":"Mu","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"G685","DOI":"10.1152\/ajpgi.00021.2020","article-title":"Liver Injury Impaired 25-Hydroxylation of Vitamin D Suppresses Intestinal Paneth Cell defensins, leading to Gut Dysbiosis and Liver Fibrogenesis","volume":"319","author":"Wu","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3748\/wjg.v21.i6.1718","article-title":"Vitamin D: A new player in non-alcoholic fatty liver disease?","volume":"21","author":"Eliades","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Zhang, X., Shang, X., Jin, S., Ma, Z., Wang, H., Ao, N., Yang, J., and Du, J. (2021). Vitamin D ameliorates high-fat-diet-induced hepatic injury via inhibiting pyroptosis and alters gut microbiota in rats. Arch. Biochem. Biophys., 705.","DOI":"10.1016\/j.abb.2021.108894"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Zhang, X.L., Chen, L., Yang, J., Zhao, S.S., Jin, S., Ao, N., Yang, J., Liu, H.X., and Du, J. (2023). Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1117644"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2741\/2865","article-title":"Protein interactions and complexes in human microRNA biogenesis and function","volume":"13","author":"Perron","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"Hayder","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Aggeletopoulou, I., and Mouzaki, A. (2023). miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032233"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41574-019-0260-0","article-title":"The clinical potential of circulating microRNAs in obesity","volume":"15","author":"Ji","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.addr.2018.01.009","article-title":"MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis","volume":"129","author":"Su","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"101581","DOI":"10.1016\/j.molmet.2022.101581","article-title":"MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives","volume":"65","author":"Hochreuter","year":"2022","journal-title":"Mol. Metab"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: From pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"35390","DOI":"10.18632\/oncotarget.15697","article-title":"Fine tuning of vitamin D receptor (VDR) activity by post-transcriptional and post-translational modifications","volume":"8","author":"Zenata","year":"2017","journal-title":"Oncotarget"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1124\/mol.109.056986","article-title":"Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b","volume":"76","author":"Komagata","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.febslet.2009.01.034","article-title":"Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation","volume":"583","author":"Ji","year":"2009","journal-title":"FEBS Lett."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/jcb.22646","article-title":"Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells","volume":"110","author":"Peng","year":"2010","journal-title":"J. Cell Biochem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13063-019-3241-7","article-title":"Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: Study protocol for a randomized clinical trial","volume":"20","author":"Sohrabpour","year":"2019","journal-title":"Trials"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1017\/S095442242100038X","article-title":"NAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways","volume":"36","author":"Zhang","year":"2023","journal-title":"Nutr. Res. Rev."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00438-017-1301-9","article-title":"New insights into vitamin D anticancer properties: Focus on miRNA modulation","volume":"292","author":"Zeljic","year":"2017","journal-title":"Mol. Genet. Genom."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1038\/s41598-018-28854-4","article-title":"Non-invasive prediction of NAFLD severity: A comprehensive, independent validation of previously postulated serum microRNA biomarkers","volume":"8","author":"Conde","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"18856","DOI":"10.1038\/s41598-019-55076-z","article-title":"Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population","volume":"9","author":"Ando","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Tan, Y., Ge, G., Pan, T., Wen, D., and Gan, J. (2014). A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0105192"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.55730\/1300-0144.5483","article-title":"Circulating mir-200c and mir-33a may be used as biomarkers for predicting high fructose corn syrup-induced fatty liver and vitamin D supplementation-related liver changes","volume":"52","year":"2022","journal-title":"Turk. J. Med. Sci."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Xu, Q., and Zhou, X. (2021). Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease. Molecules, 26.","DOI":"10.3390\/molecules26061725"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Bult\u00e9, D., and Rigamonti, C. (2023). Inflammasomes: Mechanisms of Action and Involvement in Human Diseases. Cells, 12.","DOI":"10.3390\/cells12131766"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3389\/fimmu.2018.01039","article-title":"Nucleotide-Binding Domain Leucine-Rich Repeat Containing Proteins and Intestinal Microbiota: Pivotal Players in Colitis and Colitis-Associated Cancer Development","volume":"9","author":"Prossomariti","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the Inflammasome in Liver Disease","volume":"17","author":"Szabo","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/liv.12537","article-title":"Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis","volume":"34","author":"Csak","year":"2014","journal-title":"Liver Int."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Tourkochristou, E., and Mouzaki, A. (2023). Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098288"},{"key":"ref_158","first-page":"1343","article-title":"Effect of vitamin D supplementation on various parameters in non-alcoholic fatty liver disease patients","volume":"32","author":"Hussain","year":"2019","journal-title":"Pak. J. Pharm. Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-014-0336-5","article-title":"Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial","volume":"47","author":"Sharifi","year":"2014","journal-title":"Endocrine"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1038\/s41598-022-11950-x","article-title":"Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: A systematic review and meta-analysis","volume":"12","author":"Sindhughosa","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1080\/00365521.2018.1501091","article-title":"Treatment of non-alcoholic steatohepatitis patients with vitamin D: A double-blinded, randomized, placebo-controlled pilot study","volume":"53","author":"Geier","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3945\/jn.117.254292","article-title":"Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation","volume":"147","author":"Dasarathy","year":"2017","journal-title":"J. Nutr."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Barchetta, I., Del Ben, M., Angelico, F., Di Martino, M., Fraioli, A., La Torre, G., Saulle, R., Perri, L., Morini, S., and Tiberti, C. (2016). No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. BMC Med., 14.","DOI":"10.1186\/s12916-016-0638-y"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2014-1703","article-title":"Rapid normalization of vitamin D levels: A meta-analysis","volume":"135","author":"McNally","year":"2015","journal-title":"Pediatrics"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40266-015-0259-8","article-title":"Vitamin D supplementation in nursing home patients: Randomized controlled trial of standard daily dose versus individualized loading dose regimen","volume":"32","author":"Wijnen","year":"2015","journal-title":"Drugs Aging"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Bertoldo, F., Cianferotti, L., Di Monaco, M., and Falchetti, A. (2022). Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). Nutrients, 14.","DOI":"10.3390\/nu14194148"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/9\/4901\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:37:13Z","timestamp":1760107033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/9\/4901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":166,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["ijms25094901"],"URL":"https:\/\/doi.org\/10.3390\/ijms25094901","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]}}}